The evidence was the significantly elevated secretion of IFN-γ or TNF-α by tumor-specific immune cells of RdB/IL12/DCN-treated mice compared with RdB/IL-12-treated mice (Figure 4C and 4D). This evidence concerns the gene IFNG and neoplasm.